INS and type 2 diabetes mellitus: All these negative results are however in line with recently published studies showing that dedifferentiation of β-cells, rather than an apoptotic process appears to be the main mechanism behind β-cell mass loss in T2DM, and insulin therapy could reverse the process and allow β-cell redifferentiation [36, 37].